HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohide Tamura Selected Research

Leukopenia

1/2017Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
12/2015Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors.
12/2015A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors.
11/2015A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
8/2015Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.
7/2014A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).
3/2012A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors.
10/2005Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohide Tamura Research Topics

Disease

102Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 02/2002
102Neoplasms (Cancer)
01/2019 - 02/2002
33Lung Neoplasms (Lung Cancer)
03/2021 - 07/2002
21Neutropenia
05/2019 - 02/2005
20Disease Progression
01/2021 - 02/2002
18Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2019 - 01/2002
12Thrombocytopenia (Thrombopenia)
01/2017 - 10/2005
11Diarrhea
05/2019 - 01/2002
9Nausea
10/2022 - 06/2003
8Adenocarcinoma of Lung
12/2019 - 08/2002
8Neoplasm Metastasis (Metastasis)
01/2018 - 05/2007
8Leukopenia
01/2017 - 10/2005
7Breast Neoplasms (Breast Cancer)
02/2020 - 02/2008
7Interstitial Lung Diseases (Interstitial Lung Disease)
02/2020 - 07/2004
6Vomiting
10/2022 - 06/2003
6Febrile Neutropenia
05/2019 - 01/2014
6Hypertension (High Blood Pressure)
04/2017 - 11/2006
6Carcinoma (Carcinomatosis)
04/2014 - 08/2002
5Pneumonia (Pneumonitis)
08/2016 - 10/2006
5Colorectal Neoplasms (Colorectal Cancer)
05/2014 - 02/2002
5Stomach Neoplasms (Stomach Cancer)
12/2011 - 05/2007
4Fever (Fevers)
03/2019 - 07/2006
4Anemia
01/2019 - 08/2006
4Anorexia
01/2017 - 08/2010
4Exanthema (Rash)
12/2015 - 01/2010
4Proteinuria
12/2015 - 11/2009
4Stomatitis
03/2014 - 08/2010
3Lung Injury
02/2020 - 07/2006
3Pleural Effusion (Pleural Effusions)
03/2019 - 07/2006
3Headache (Headaches)
04/2017 - 11/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 08/2002
3Fatigue
02/2016 - 06/2003
3Radiation Pneumonitis
01/2014 - 07/2006
3Adenocarcinoma
07/2004 - 08/2002
2Bronchiectasis
12/2021 - 01/2017
2Thymoma (Thymic Carcinoma)
03/2020 - 08/2011
2Melanoma (Melanoma, Malignant)
01/2018 - 10/2017

Drug/Important Bio-Agent (IBA)

38Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2002
31ErbB Receptors (EGF Receptor)IBA
12/2019 - 02/2002
22PlatinumIBA
06/2020 - 10/2002
21Pharmaceutical PreparationsIBA
02/2020 - 07/2003
21Gefitinib (Iressa)FDA Link
09/2015 - 02/2002
19Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 12/2003
17Tyrosine Kinase InhibitorsIBA
12/2019 - 02/2002
16Carboplatin (JM8)FDA LinkGeneric
01/2019 - 04/2005
16Irinotecan (Camptosar)FDA LinkGeneric
08/2016 - 01/2002
14Docetaxel (Taxotere)FDA Link
03/2021 - 10/2003
12Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2017 - 02/2002
11Biomarkers (Surrogate Marker)IBA
12/2015 - 11/2005
8Phosphotransferases (Kinase)IBA
01/2019 - 05/2011
8Pemetrexed (MTA)FDA Link
01/2019 - 07/2008
8amrubicinIBA
01/2017 - 03/2010
8Etoposide (VP 16)FDA LinkGeneric
08/2016 - 01/2002
7NivolumabIBA
01/2021 - 01/2016
7alectinibIBA
01/2020 - 06/2013
6CrizotinibIBA
01/2020 - 06/2013
6Alanine Transaminase (SGPT)IBA
01/2019 - 12/2003
5GemcitabineFDA Link
06/2019 - 02/2002
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019 - 10/2005
5Monoclonal AntibodiesIBA
01/2016 - 02/2002
5Vinorelbine (Navelbine)FDA LinkGeneric
08/2013 - 08/2004
5Proteins (Proteins, Gene)FDA Link
02/2012 - 01/2004
5Antineoplastic Agents (Antineoplastics)IBA
02/2008 - 02/2002
5DNA (Deoxyribonucleic Acid)IBA
07/2006 - 08/2002
4lenvatinibIBA
12/2019 - 04/2011
4Hemoglobins (Hemoglobin)IBA
08/2015 - 08/2006
4Biological ProductsIBA
05/2011 - 07/2003
3Palonosetron (Aloxi)FDA Link
06/2022 - 02/2019
3Neurokinin-1 Receptor AntagonistsIBA
01/2022 - 02/2019
3necitumumabIBA
06/2019 - 11/2016
3Anaplastic Lymphoma KinaseIBA
01/2018 - 01/2017
3SteroidsIBA
01/2017 - 07/2006
3Histone Deacetylase InhibitorsIBA
01/2017 - 09/2009
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2015 - 05/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 11/2009
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2014 - 10/2010
3Cetuximab (Erbitux)FDA Link
05/2014 - 02/2002
3CreatinineIBA
11/2013 - 12/2009
3Cytochrome P-450 CYP3AIBA
08/2008 - 02/2005
3vandetanib (ZD6474)IBA
11/2006 - 12/2004
3Topoisomerase I InhibitorsIBA
08/2006 - 01/2002
2fosaprepitantFDA Link
10/2022 - 06/2022
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 02/2016
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 07/2006
2B7-H1 AntigenIBA
06/2020 - 09/2015
2ProdrugsIBA
11/2019 - 06/2013
2Immune Checkpoint InhibitorsIBA
01/2019 - 01/2016
2Tyrosine (L-Tyrosine)FDA Link
01/2019 - 05/2011
2IpilimumabIBA
10/2017 - 08/2015
2RamucirumabIBA
04/2017 - 01/2016
2resminostatIBA
01/2017 - 06/2015

Therapy/Procedure

61Drug Therapy (Chemotherapy)
10/2022 - 02/2002
43Therapeutics
01/2021 - 02/2002
24Radiotherapy
03/2020 - 07/2002
17Chemoradiotherapy
01/2017 - 08/2003
4Combination Drug Therapy (Combination Chemotherapy)
08/2016 - 08/2011
4Intravenous Infusions
02/2016 - 04/2008
3Adjuvant Chemotherapy
09/2014 - 06/2006
2Traction
12/2021 - 01/2017
2Immunotherapy
12/2019 - 01/2017